Studies have shown that apigenin reduces nuclear c-Myc and intracellular HIF-1α protein level in a dose-dependent manner, which leads to significant tumor inhibition (Liu et al., 2005; Shukla et al., 2007). The gene discussed is HIF1A; the disease is neoplasm.